U.S. Physical Therapy (USPH) Scheduled to Post Earnings on Tuesday

U.S. Physical Therapy (NYSE:USPH) will issue its quarterly earnings data after the market closes on Tuesday, August 13th. Analysts expect the company to announce earnings of $0.81 per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

U.S. Physical Therapy Stock Performance

NYSE:USPH opened at $88.36 on Monday. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of 0.28. The company has a market capitalization of $1.33 billion, a P/E ratio of 71.84, a price-to-earnings-growth ratio of 3.52 and a beta of 1.38. The firm has a 50-day moving average price of $94.63 and a two-hundred day moving average price of $99.98. U.S. Physical Therapy has a twelve month low of $78.08 and a twelve month high of $114.15.

Analysts Set New Price Targets

Separately, Barrington Research restated an “outperform” rating and set a $122.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, May 9th. One analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $119.50.

Insider Buying and Selling at U.S. Physical Therapy

In other news, Director Edward L. Kuntz sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $107.57, for a total value of $268,925.00. Following the completion of the transaction, the director now owns 3,280 shares of the company’s stock, valued at $352,829.60. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, CEO Christopher J. Reading sold 2,900 shares of the company’s stock in a transaction dated Thursday, May 30th. The shares were sold at an average price of $100.26, for a total transaction of $290,754.00. Following the completion of the transaction, the chief executive officer now owns 95,838 shares of the company’s stock, valued at approximately $9,608,717.88. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Edward L. Kuntz sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $107.57, for a total transaction of $268,925.00. Following the completion of the sale, the director now directly owns 3,280 shares in the company, valued at $352,829.60. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,500 shares of company stock worth $672,022. Corporate insiders own 1.70% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.